Compositions for treating pseudomonas infection

US9056081B2 · kind B2 · utility

Assignees

• UNIVERSITÄTSKLINIKUM HAMBURG—EPPENDORF · DE
• Heinrich-Heine-Universitat Dusseldorf · DE

Inventors

• Melita Schachner · Hamburg, DE
• Heike Gustke · Hamburg, DE
• Udo Schumacher · Bargteheide, DE
• Karl-Erich Jäger · Wetter (Ruhr), DE

Key dates

• Filing date: May 10, 2010
• Grant date: Jun 16, 2015
• Expiry date: Jun 25, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to a HNK-I mimetic peptide or a polypeptide comprising such HNK-I mimetic peptide for treating or preventing a Pseudomonas infection, in particular an infection with Pseudomonas aeruginosa. The invention further relates to the use of a HNK-I mimetic peptide or a polypeptide comprising such HNK-I mimetic peptide for the preparation of a pharmaceutical composition for treating or preventing a Pseudomonas infection. The invention also relates to a pharmaceutical composition comprising a HNK-I mimetic peptide or a polypeptide comprising such HNK-I mimetic peptide, wherein the composition is for treating or preventing a Pseudomonas infection.